PLIs diagrams of (a) 3e, (b) 3f, (c) 3i, (d) 3r, (e) 5a, and (f) selegiline in the ligand-binding domain of MAO-B (PDB ID 2V5Z) (the legend is the same as that presented in Fig. 1).

 
 
  Part of: Kondeva-Burdina M, Krastev K, Pencheva T, Angelova VT (2025) Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases. Pharmacia 72: 1-13. https://doi.org/10.3897/pharmacia.72.e155372